- JP-listed companies
- RIBOMIC Inc.
- Ownership
RIBOMIC Inc. (4591) Shareholders
Market cap
¥4.1B
P/E ratio
-2.3x
Ribomics develops next-generation aptamer drugs using its proprietary RiboART System to treat unmet medical needs like achondroplasia and eye diseases.
大株主
| （単位：千株） | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BNP PARIBAS LONDON BRANCH FOR PRIME BROKERAGE CLEARANCE ACC FOR THIRD PARTY | 1,533 2.82% | ||||||||||
| BNY GCM CLIENT ACCOUNT JPRD AC ISG | 992.147 1.82% | ||||||||||
| 松井証券 | 534.8 1.87% | 687.3 1.92% | 318.2 0.88% | 491.7 1.1% | 855.4 1.57% | ||||||
| UBS AG LONDON A/C IPB SEGREGATED CLIENT ACCOUNT | 512.7 1.14% | 632.6 1.16% | |||||||||
| 大和証券 | 298.6 1.04% | 353.8 0.99% | 399.8 0.89% | 598.1 1.1% | |||||||
| 全薬工業 | 1,025.8 7.8% | 1,025.8 7.72% | 1,025.8 7.21% | 1,025.8 7.12% | 1,025.8 5.84% | 1,025.8 3.67% | 575.8 2.01% | 575.8 1.61% | 575.8 1.59% | 575.8 1.29% | 575.8 1.06% |
| 中村 義一 | 568 1.04% | ||||||||||
| 楽天証券株式会社共有口 | 542.8 0.99% | ||||||||||
| 湯浅 英之 | 500 0.92% | ||||||||||
| SBI証券 | 259.1 1.82% | 178.205 1.23% | 409.826 1.46% | 727.723 2.54% | 714.944 2% | 230.91 0.64% | 365.14 0.81% | 395.84 0.72% | |||
| 楽天証券 | 648.2 2.32% | 635.3 2.22% | 1,345 3.76% | 1,207 3.35% | 2,791.7 6.26% | ||||||
| NOMURA INTERNATIONAL PLC A/C JAPAN FLOW | 691.1 1.54% | ||||||||||
| 中村義一 | 568 4.32% | 568 4.27% | 568 3.99% | 568 3.94% | 568 3.23% | 568 2.03% | 568 1.98% | 568 1.59% | 568 1.57% | 568 1.27% | |
| 湯浅英之 | 500 1.12% | ||||||||||
| BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE | 324.217 0.72% | ||||||||||
| 今津秀 | 355.1 1.27% | 488.2 1.7% | 493.7 1.38% | 403.3 1.12% | |||||||
| マネックス証券 | 310.722 0.86% | ||||||||||
| 藤本製薬 | 300 2.28% | 300 2.25% | 300 2.11% | 300 2.08% | 300 1.7% | 300 1.07% | 300 1.05% | 300 0.84% | 300 0.83% | ||
| 中村恵美子 | 271 2.06% | 271 2.03% | 271 1.9% | 279 1.93% | 287 1.63% | 295 1.05% | 295 1.03% | 295 0.82% | 295 0.81% | ||
| 野村證券 | 272.8 0.75% | ||||||||||
| 日本証券金融 | 313 1.12% | 841.3 2.35% | |||||||||
| JPモルガン証券 | 326.3 1.14% | ||||||||||
| 大塚製薬 | 4,000 30.43% | 4,000 30.1% | 4,000 28.14% | 4,000 27.79% | 4,000 22.78% | 4,000 14.33% | |||||
| 大家功司 | 320 1.14% | ||||||||||
| 河上弘 | 201 1.14% | ||||||||||
| 中村陽子 | 200 1.52% | 200 1.5% | 200 1.38% | 200 1.13% | |||||||
| 江平文茂 | 165 0.93% | ||||||||||
| CREDIT SUISSE AG, SINGAPORE BRANCH - FIRM EQUITY | 147.9 0.84% | ||||||||||
| 宮川伸 | 325.4 2.47% | 325.4 2.44% | 248.7 1.74% | 142.4 0.81% | |||||||
| 佐々木桂一 | 241.1 1.69% | 637.5 4.43% | |||||||||
| 五味大輔 | 200 1.38% | ||||||||||
| 吉村光司 | 180 1.25% | ||||||||||
| 新井計男 | 255.6 1.92% | 609.9 4.29% | |||||||||
| カブドットコム証券 | 267.4 1.88% | ||||||||||
| 大和企業投資 | 162.2 1.23% | 162.2 1.22% | |||||||||
| 岩井化学薬品 | 160 1.21% | 160 1.2% | |||||||||
| 藤原將寿 | 110 0.83% | ||||||||||
| 計 | 7,122.4 54.18% | 7,268 54.7% | 7,791 54.81% | 7,568.505 52.59% | 7,037.1 40.08% | 8,234.926 29.5% | 4,749.723 16.63% | 6,174.844 17.3% | 4,481.732 12.4% | 7,220.157 16.19% | 7,193.687 13.25% |